The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancer

scientific article published on 01 June 1992

The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00008571-199206000-00004
P953full work available at URLhttps://journals.lww.com/00008571-199206000-00004
P698PubMed publication ID1306112

P2093author name stringP. Smith
R. A. Branch
G. R. Wilkinson
C. M. Fleming
A. Kaisary
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectgeneticsQ7162
bladder cancerQ504775
P304page(s)128-134
P577publication date1992-06-01
P1433published inPharmacogenetics and GenomicsQ10534561
P1476titleThe ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancer
P478volume2

Reverse relations

cites work (P2860)
Q36832297Epidemiology of urinary bladder cancer: from tumor development to patient's death
Q38855185The CYP2D6 extensive metabolizer genotype is associated with increased risk for bladder cancer.
Q73846452Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes

Search more.